Arvinas, Inc.
ARVNBiotechnology
$7.90+3.95%As of Oct 29vs prior close
- Market cap
- $516.6M
- P/E (TTM)
- 29.3×
- From 52W high
- −42.88%
- EPS (LTM)
- $0.24
- Revenue (YE25)
- $262.6M
- Dividend yield
- 0.00%
Nomior Score
29
Steady ProfileSpeculativeBottom 14% of the scored universe
Growth37
Quality51
Value—
Momentum22
Resilience34
Growth
+55.76%revenue a year over 8 fiscal years
YE17 $7.6MYE25 $262.6M
Connections
Revenue to profitQ2 YE26
68% of revenue became net profit, up 341 pts on a year.
Who owns it
2funds